| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2b4be2300a741a69aa1b8bb47a88899f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-316 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y306-01001
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-62 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| filingDate |
2021-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d50eb8900e6f6c8609c4f1e62f0b0a2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_efe2f9989426f27a057989f9e3e933c5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63b2bc59cc830a3361e9a04d1520e5fb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_015f184ac56318d8bdf787861e1c3d52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f520ee53b9fc1bd1acd241db7bf5a9ee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea5679a75f399ac43ab86a1d51a52b69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f99ec5e724d75e6e6b8be5cd2c7df54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e843cf5b682aa811ebfa4f8942298a7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df32e29712126c886d1aa38ee9160c29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3be81ff1493c1f27af06f401dc5febf4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c875c1642409f2ac17f55a16e69db7ea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d880bda42814e3c81ec4ea46efcb0ce2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27f9a097b7129109f35f029089c2ea50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d988c0dcdf7154820520553815f4471
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9159947fbc16c3a3a6590cd1a6edb7d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f0f9eff3e9c02d9185d56ab66a9b984 |
| publicationDate |
2022-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20220158291-A |
| titleOfInvention |
A pharmaceutical composition containing cell-transducing Inorganic Pyrophosphatase 1 fusion protein for preventing or treating motor neuronal disorder |
| abstract |
Challenge: To provide drugs for the treatment of neurological diseases that have little or no side effects and are highly effective. Solution: The present invention relates to a pharmaceutical composition for the treatment of neurological diseases comprising a cell-permeable PPA1 fusion protein. reduced DNA fragmentation induced by These results suggest that the PPA1 fusion protein has a protective effect against apoptosis and a therapeutic effect that protects neurons from neurological disease damage. |
| priorityDate |
2021-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |